Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Monday, May 3, 2021

Pneumonia Short Treatment

REBEL EM - May 3, 2021 - By Marco Propersi
Paper: Dinh A et al. Discontinuing β-Lactam Treatment After 3 Days for Patients with Community-Acquired Pneumonia in Non-Critical Care Wards (PTC): A Double-Blind, Randomised, Placebo-Controlled, Non-Inferiority Trial. Lancet 2021. PMID: 33773631
“Clinical Question: Is a 3-day course of β-lactam therapy “not worse” than an 8-day course for admitted patients with CAP who are not critically ill?
Authors Conclusion: Among patients admitted to hospital with community-acquired pneumonia who met clinical stability criteria, discontinuing β-lactam treatment after three days was non-inferior to 8 days of treatment. These findings could allow a substantial reduction of antibiotic consumption.“
Clinical Bottom Line:
The authors found that three days of β-lactam therapy was non-inferior to 8 days of β-lactam therapy in treatment for select patients with CAP who were not admitted to the ICU. However, we believe large multinational trials are needed before instituting major practice changes.”